Trial intelligence / Profile preview

Intramuscular clodronate 200 mg for painful hand osteoarthritis (6‑month open pilot study)

2013-000832-85Phase 4Active

Sponsor
Fondazione Salvatore Maugeri
Start
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of clodronate in hand osteoarthritis, sponsored by Fondazione Salvatore Maugeri. Primary endpoint: Efficacy and tolerability of intramuscular clodronate 200 mg. Started Aug 2013; status: active.

02

Drugs

clodronate
03

Conditions

hand osteoarthritis

Beyond the preview

Go deeper on 2013-000832-85.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000832-85.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call